Boston Scientific (BSX) Tops Q3 EPS by 4c; beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Stifel on Boston Scientific (BSX): 'We expect especially positive growth contributions from Watchman and Electrophysiology'
October 22, 2025 12:47 PM EDTStifel analyst Rick Wise reiterated a Buy rating and $125.00 price target on Boston Scientific (NYSE: BSX).
The analyst comments "Coming away from Boston Scientifics late September biennial Analyst meeting, we strongly felt that the companys 2026-2028 double-digit revenue growth outlook was highly credible... More
